fda semaglutide shortage lawsuit

fda semaglutide shortage lawsuit 🚨 A major just escalated pressure on compounded GLP-1s in Med Spas Last week, Novo Nordisk filed suit against telehealth company Hims & Hers over compounded products, signaling intensifying legal Hims & Hers Health (HIMS)

Name: fda semaglutide shortage lawsuit 🚨 A major just escalated pressure on compounded GLP-1s in Med Spas Last week, Novo Nordisk filed suit against telehealth company Hims & Hers over compounded products, signaling intensifying legal Hims & Hers Health (HIMS)
Brand: museeartisanaletruralclion.fr
SKU: 59849881419
Price: 24.29 USD
Availability: InStock
Rating: 4.3546000000000005 (10 reviews)

SKU: 59849881419

4.4

EUR24.29 EUR64.29

Pay in 4 interest-free payments of $6.07 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 31 - Sep 5

Description

Injection-Related Risks With Injectable GHK-Cu FDA identifies compounded injectable drugs containing GHK-Cu as a potential immunogenicity risk because of aggregation and peptide-related impurities, and FDA notes limited human data to inform safety considerations [8]

It is important to note that references to these compounds in 'anti-ageing' contexts reflect marketing claims rather than established clinical benefit